IL84312A - Ifosfamide lyophilisate and its preparation - Google Patents

Ifosfamide lyophilisate and its preparation

Info

Publication number
IL84312A
IL84312A IL84312A IL8431287A IL84312A IL 84312 A IL84312 A IL 84312A IL 84312 A IL84312 A IL 84312A IL 8431287 A IL8431287 A IL 8431287A IL 84312 A IL84312 A IL 84312A
Authority
IL
Israel
Prior art keywords
ifosfamide
preparation
lyophilisate
ifosfamide lyophilisate
weight
Prior art date
Application number
IL84312A
Other languages
English (en)
Other versions
IL84312A0 (en
Original Assignee
Asta Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Pharma Ag filed Critical Asta Pharma Ag
Publication of IL84312A0 publication Critical patent/IL84312A0/xx
Publication of IL84312A publication Critical patent/IL84312A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/675Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cephalosporin Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Control Of El Displays (AREA)
  • Amplifiers (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL84312A 1986-10-31 1987-10-29 Ifosfamide lyophilisate and its preparation IL84312A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3637089 1986-10-31

Publications (2)

Publication Number Publication Date
IL84312A0 IL84312A0 (en) 1988-03-31
IL84312A true IL84312A (en) 1991-11-21

Family

ID=6312873

Family Applications (1)

Application Number Title Priority Date Filing Date
IL84312A IL84312A (en) 1986-10-31 1987-10-29 Ifosfamide lyophilisate and its preparation

Country Status (25)

Country Link
EP (1) EP0265812B1 (2)
JP (1) JPS63159319A (2)
KR (1) KR900003491B1 (2)
AT (1) ATE55250T1 (2)
AU (1) AU598602B2 (2)
CA (1) CA1314231C (2)
DD (1) DD262582A5 (2)
DE (1) DE3764235D1 (2)
DK (1) DK169308B1 (2)
EG (1) EG18333A (2)
ES (1) ES2017982B3 (2)
FI (1) FI87140C (2)
GE (1) GEP19971025B (2)
GR (1) GR3000708T3 (2)
HU (1) HU197987B (2)
IL (1) IL84312A (2)
IN (1) IN168119B (2)
LV (1) LV10051B (2)
MX (1) MX8958A (2)
NO (1) NO873860L (2)
PT (1) PT86032B (2)
RU (1) RU1836079C (2)
UA (1) UA11075A (2)
YU (1) YU197387A (2)
ZA (1) ZA878183B (2)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE58900183D1 (de) * 1988-03-19 1991-08-29 Asta Pharma Ag Ifosfamid-mesna-lyophilisat und verfahren zu dessen herstellung.
US5227373A (en) * 1991-10-23 1993-07-13 Bristol-Myers Squibb Co. Lyophilized ifosfamide compositions
WO1995007083A1 (en) * 1993-09-10 1995-03-16 F.H. Faulding & Co. Limited Ifosfamide lyophilisate composition
DE19529057B4 (de) * 1995-08-08 2007-12-13 Baxter Healthcare S.A. Ifosfamid-Lyophilisat-Zubereitungen
JP2002505282A (ja) * 1998-03-03 2002-02-19 塩野義製薬株式会社 ホスホリパーゼ阻害剤の[[3−(2−アミノ−1,2−ジオキソエチル)−2−エチル−1−フェニルメチル)−1h−インドール−4−イル]オキシ]酢酸ナトリウムを含む薬学的組成物
MXPA05002453A (es) * 2002-09-05 2005-05-27 Bharat Serums & Vaccines Ltd Composicion estable liquida de oxazafosforina con el 2-mercaptoetansulfonato de sodio.
NZ540484A (en) * 2002-12-02 2008-03-28 Bharat Serums & Vaccines Ltd Stable, clear, aqueous ifosfamide compositions for parenteral administration and a process for their preparation
US8436190B2 (en) * 2005-01-14 2013-05-07 Cephalon, Inc. Bendamustine pharmaceutical compositions
SI2071917T1 (sl) * 2006-09-29 2013-03-29 Infa S.A. Pakirni sistem za farmacevtske sestavke in komplet za intravensko aplikacijo
WO2016087001A1 (en) * 2014-12-04 2016-06-09 Huawei Technologies Co., Ltd. Load allocation in a data communication network

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3732340A (en) * 1966-07-11 1973-05-08 Asta Werke Ag Chem Fab N',o-propylene phosphoric acid ester diamides
DE2750207A1 (de) * 1977-05-09 1978-11-16 Walton J Smith Gefriergetrocknete zusammensetzungen, insbesondere gefriergetrocknete pharmazeutische praeparate und verfahren zu deren herstellung
EP0083439B1 (de) * 1981-12-31 1989-07-26 ASTA Pharma AG 4-Sulfido-oxazaphosphorine und deren Verwendung bei der Krebsbekämpfung und zur Immunsuppression
US4537883A (en) * 1982-11-12 1985-08-27 Mead Johnson & Company Lyophilized cyclophosphamide

Also Published As

Publication number Publication date
ES2017982B3 (es) 1991-03-16
LV10051B (en) 1995-06-20
HU197987B (en) 1989-07-28
JPS63159319A (ja) 1988-07-02
FI874727L (fi) 1988-05-01
GR3000708T3 (en) 1991-10-10
RU1836079C (ru) 1993-08-23
GEP19971025B (en) 1997-04-06
EG18333A (en) 1993-12-30
AU598602B2 (en) 1990-06-28
EP0265812B1 (de) 1990-08-08
AU8052987A (en) 1988-05-05
JPH0543684B2 (2) 1993-07-02
FI87140B (fi) 1992-08-31
EP0265812A1 (de) 1988-05-04
ZA878183B (en) 1988-05-02
DK169308B1 (da) 1994-10-10
LV10051A (lv) 1994-05-10
FI87140C (fi) 1992-12-10
MX8958A (es) 1993-12-01
UA11075A (uk) 1996-12-25
IN168119B (2) 1991-02-09
DK569687A (da) 1988-05-01
CA1314231C (en) 1993-03-09
NO873860D0 (no) 1987-09-15
DD262582A5 (de) 1988-12-07
DE3764235D1 (de) 1990-09-13
YU197387A (en) 1988-12-31
HUT44932A (en) 1988-05-30
IL84312A0 (en) 1988-03-31
ATE55250T1 (de) 1990-08-15
NO873860L (no) 1988-05-02
FI874727A0 (fi) 1987-10-27
DK569687D0 (da) 1987-10-30
KR880004814A (ko) 1988-06-27
KR900003491B1 (ko) 1990-05-21
PT86032A (de) 1987-11-01
PT86032B (pt) 1990-08-31

Similar Documents

Publication Publication Date Title
EP0348808A3 (de) Neue Arzneimittelformulierung sowie Verfahren zu deren Herstellung
GB8712073D0 (en) Medicament
EP0427247A3 (en) Pharmaceutical composition with r-alpha-lipoic acid or s-alpha-lipoic acid as the active ingredient
EP0196524A3 (en) Phenoxyalkylaminopyrimidine derivatives, their preparation and insecticidal and acaricidal compositions containing them
GR3002377T3 (en) Ifosfamide-mesna-lyophilized composition and process to prepare it
HUT44438A (en) Composition comprising l-dopa
IL86798A (en) 2,2-dimethylchroman-3-ol derivatives, their preparation and pharmaceutical compositions containing them
IL84312A0 (en) Ifosfamide lyophilisate and its preparation
PT86205A (en) Process for the preparation of 3-]omega-(3,5-di-t-butil-4-hydroxyphenyl)-alkanoyl"pyrroles and their de-oxy analogs useful in therapy
ZA886107B (en) Antiviral preparation
JPS6426592A (en) Novel 3', 4'-nitrogen disubstituted epipodophylotoxine glucoside derivative
IL84551A0 (en) Peptides,their preparation and pharmaceutical compositions containing them
IL82145A0 (en) Substituted thiacycloalkeno(3,2-b)pyridines,their preparation and pharmaceutical compositions containing them
KR900700484A (ko) 1,4:3,6-디안히드로 헥시톨 잘산염의 아미노프로판올 유도체,그의 제법 및 약제로서의 그의 용도
IL85651A0 (en) Optically active oxo-isoindolinyl derivatives,their preparation and pharmaceutical compositions containing them
OA09419A (fr) Dérivés de l'acide 3-pyrrolidinylthio-1-azabicyclo (3.2.0.) -hept-2-ene-2-carboxylique et leur préparation.
IL87173A (en) 4-heterocyclyl thio-phenyl-thiourea,isothiourea and/or carbodiimide derivatives,their preparation and insecticidal and acaricidal compositions containing them
IL83370A0 (en) Preparation of 3,4-diamino-5-benzylpyrimidines
GB8906580D0 (en) Preparation of 2,6-dioxopiperidine derivatives
IL88849A0 (en) Preparation of 1,5-benzo-thiazepine derivatives
IL83606A0 (en) Derivatives of 2,2-dimethyl-cyclopropanecarboxylic acid,their preparation and their use as insecticides and acaricides
IL87792A0 (en) 1,3-diazocycloalkene derivatives,their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired